Advances in Surgeries for Treating Common Skin Cancers
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Dermatology".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 1036
Special Issue Editor
Interests: melanoma; non-melanoma skin cancer; dermoscopy; reflectance confocal microscopy; immunotherapy; targeted therapies; dermatologic adverse events of oncological treatment; ablative treatments
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Over the past few decades, there has been a large increase in the incidence of melanoma and non-melanoma skin cancers (NMSCs). Although great therapeutic progress has been made in the treatment of locally advanced and metastatic cases, mainly thanks to immunotherapy and targeted therapy, patients with a large number of skin cancers within the face and scalp, skin mets, or genetic syndromes remain a huge challenge. Neoadjuvant treatment significantly changed patient outcomes as it has the potential to downstage unresectable disease and allow for curativeintent operative resection. However, the precise preoperative diagnostics and mapping of negative margins remains challenging in lentigo maligna /lentigo maligna melanoma lesions. Reflectance confocal microscopy and Mohs microsurgery have been used as supports, although are still not widely available. The use of electrochemo-therapy and ablative treatments are alternatives for multiple NMSCs and melanoma skin metastases. New methods and techniques for reconstructive surgery of the resultant defects, supported by tissue engineering and 3D modeling, are becoming more available and continue to evolve. This Special Issue aims to present not only current achievements in the field of skin cancer surgery, but also in an interdisciplinary context along with changing therapeutic strategies.
Dr. Monika Slowinska
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- melanoma
- non-melanoma skin cancers
- surgery
- reconstruction
- mohs microsurgery
- ablative treatments
- tissue engineering
- pre-operative diagnostics
